product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-YB1 (Ser102) (C34A2) Rabbit mAb
catalog :
2900S
quantity :
100 ul
price :
274 USD
clonality :
monoclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat, cow
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/DilutionReference
  • western blot; human; 1:500
Jung K, Wu F, Wang P, Ye X, Abdulkarim B, Lai R. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells. BMC Cancer. 2014;14:328 pubmed publisher
Finkbeiner M, Astanehe A, To K, Fotovati A, Davies A, Zhao Y, et al. Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells. Oncogene. 2009;28:1421-31 pubmed publisher
product information
SKU :
2900S
Product-Name :
Phospho-YB1 (Ser102) (C34A2) Rabbit mAb
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, Mk, (R, B)
Applications :
Western blot
Product-Category :
PI3K / Akt Signaling
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
49
Host :
Rabbit
Target :
YB1 (Ser102) phosphate
Primary-Protein :
YB-1
Alt-Names :
BP-8,CBF-A,CCAAT-binding transcription factor I subunit A,CSDA2,CSDB,DBPB,DNA-binding protein B,EFI-A,Enhancer factor I subunit A,MDR-NF1,MGC104858,MGC110976,MGC117250,NSEP-1,NSEP1,Nuclease-sensitive element-binding protein 1,Y box binding protein 1,Y-box transcription factor,Y-box-binding protein 1,YB-1,YB1,YBOX1,YBX1,major histocompatibility complex, class II, Y box-binding protein I,nuclease sensitive element binding protein 1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.